Heteroaromatic quinoline compounds and their use as PDE10 inhibitors

Details for Australian Patent Application No. 2005323794 (hide)

Owner Pfizer Products Inc.

Inventors Hoover, Dennis Jay; Helal, Christopher John; Humphrey, John Michael; Verhoest, Patrick Robert

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-B-2005323794

PCT Pub. Number WO2006/072828

Priority 60/642,058 07.01.05 US

Filing date 22 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 19 July 2012

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/14 - Quaternary ammonium compounds, e.g. edrophonium, choline

A61P 25/18 Drugs for disorders of the nervous system

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/072828 Priority application(s): WO2006/072828

19 July 2012 Application Accepted

  Published as AU-B-2005323794

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323797-Pyrrolopyrazoles, potent kinase inhibitors

2005323771-Gastrointestinal tool over guiding element